Novartis begins shipment of Fluvirin® seasonal influenza vaccine to US customers
- Details
- Category: Novartis
![Novartis Novartis](/images/stories/logo/novartis_b.gif)
XGEVA® (Denosumab) Granted Marketing Authorization in the European Union
- Details
- Category: Amgen
![Amgen Amgen](/images/stories/logo/amgen.gif)
Roche provides update from FDA hearing on Avastin for metastatic breast cancer
- Details
- Category: Roche
![Roche Roche](/images/stories/logo/roche.gif)
Lilly CEO Says Biopharmaceuticals Should Be Included in Transatlantic Trade and Economic Discussions
- Details
- Category: Eli Lilly and Company
![Eli Lilly and Company Eli Lilly and Company](/images/stories/logo/lilly.gif)
Sanofi Reports Positive Top-Line Results from First Phase 3 Study of Alemtuzumab in Multiple Sclerosis
- Details
- Category: Genzyme
![Genzyme Genzyme](/images/stories/logo/genzyme.gif)
Boehringer Ingelheim and Ashoka's Changemakers Launch "Making More Health" Competition
- Details
- Category: Boehringer Ingelheim
![Boehringer Ingelheim Boehringer Ingelheim](/images/stories/logo/boehringeringelheim.gif)
Phase III trial of Novartis drug Afinitor® met primary endpoint
- Details
- Category: Novartis
![Novartis Novartis](/images/stories/logo/novartis_b.gif)
More Pharma News ...
- Pfizer to Explore Strategic Alternatives for its Animal Health and Nutrition Businesses
- Bristol-Myers Squibb and Innate Pharma Announce Breakthrough Global License Agreement
- Amgen and UCB Team Up with NASA
- London 2012 partner, GlaxoSmithKline, shares scientific expertise with World Anti-Doping Agency
- Novartis receives FDA approval for Arcapta(TM) Neohaler(TM)
- Pfizer and ChemRar to Explore Innovative Medical Research and Development Partnership in Russia
- Bayer advances research in the area of pulmonary hypertension